Introduction
Diabetic nephropathy (DN) is one of the most common microangiopathies and ultimately leads to chronic renal failure. Hypertrophy of the mesangial cell and accumulation of the extracellular matrix (ECM) in the mesangial region is mainly composed of glomerulosclerosis. High glucose is presumed an initiating agent and increased transforming growth factor-β 1 (TGF-β 1 ) is thought the key cytokine involved in the progression of DN [1] . It has been found that the kidneys of DN rats exhibit oxidative stress [2] . Studies have found that high glucose can induce oxidative stress or reactive oxygen species (ROS) expressions and TGF-β 1 synthesis in cultured mesangial cells [1, 3] . The addition of antioxidants to high glucose caused a significant reversal of fibronectin and collagen IV gene expressions [3, 4] . TGF-β 1 plays an important role in cell hypertrophy and glomerular ECM accumulation by autocrine and paracrine methods. Interestingly, it has been found that ACE-inhibitors or Ang II receptor blockers can lower enhanced TGF-β 1 and mesangial matrix accumulation [5] . This effect may be via the reduction of Ang II-stimulated TGF-β 1 production [6] . With diabetes mellitus, high glucose and many factors including TGF-β 1 , Ang II and ROS may also activate various kinds of signals that arrest cells in the G 1 phase inducing cell hypertrophy. It has also been found that hypertrophic cells could secrete more ECM [7] . Both create an infernal circle that leads to the aggravation of DN.
A central component of TGF-β 1 -stimulated ECM accumulation is the TGF-β 1 family-specific Smad signal transduction pathway. TGF-β 1 activates Smad2/3 by activating TGF-β 1 receptors, after which it partners with Smad4 and translocates to the nucleus, where they act as transcriptional regulators of target genes including TGF-β 1 , tissue inhibitors of metalloproteinase (TIMP), collagen IV and laminin [8] . Smad6 and Smad7, the inhibitory Smads, appear to specifically inhibit Smad2/3 activation by blocking its access to TGF-β 1 receptors.
Ginkgo biloba extract (EGb) is taken from the leaves of ginkgo biloba by modern extraction techniques. It is a mixture containing flavonoid glycosides (>24%) including quercetin, kaempferol, isorhamnethin, and terpene lactones (>8%) including bilobalide, ginkgolide. It has been found that EGb ameliorates hemodynamics, suppresses plateletactivating factor (PAF), scavenges ROS, relaxes vascular smooth muscles, and so on [9, 10] . It has also been found that flavonoid glycosides have the effect of suppressing ACE activity and suppressing glycation end-products (AGE) expression [11, 12] . All of these offer us a pharmacological foundation of EGb for DN therapy. Many scholars have explored the effects of EGb and ascertained its protective effects on DN in vivo. Most of EGb's protective qualities were thought to be closely related to its hemodynamic action. On the cellular level, however, the protective mechanisms of EGb on glomerulosclerosis of DN have not been identified.
In our present work, using captopril as an antifibrotic control drug, we studied the possible influence of EGb in mesangial cells on the level of cell cycle, TGF-β 1 , Smad2/3, Smad7, collagen IV, laminin and antioxidases, which were all closely related to the glomerulosclerosis of DN. Considering that EGb can not dissolve in water completely, EGb and DMEM with D-glucose at 25 mmol/L were mixed with 1.0 % ethanol in different concentrations.
Materials and methods

Materials
Mesangial cell culture Taking the 5th-8th generation of mesangial cells, after incubating 24 h under normal conditions (containing 5.56 mmol/L glucose, 10% FBS, 100 IU/mL penicillin and 100 mg/mL streptomycin, 37 ºC, 5% CO 2 ), we divided the cells into 7 groups, of which every group contained 6 bottles: normal glucose group (NS; DMEM), solvent control group (ET; 1.0% ethanol-DMEM), high glucose group (HG; 25 mmol/L glucose-DMEM), low dose of EGb group (GL; 10 µg/mL EGb-25 mmol/L glucose -DMEM), moderate dose of EGb group (GM; 20 µg/mL EGb-25 mmol/L glucose -DMEM), high dose of EGb group (GH; 40 µg/mL EGb-25 mmol/L glucose -DMEM), and captopril group (1 µmol/ mL captopril-25 mmol/L glucose -DMEM). Cells were harvested after 48 h incubation. Adjusting the cell population to 1.5×10 6 /mL, we took 1 mL of cell suspension from every group. The suspensions were then centrifuged three times at 100×g at 4 ºC for 8 min. The cell pellet was then added into 2 mL of cell lysis solution. After being shaken severely, the mixture was centrifuged at 650×g at 4 ºC for 8 min. The supernatants were stored at -20 ºC for analysis at a later stage.
Cell cycle analysis by flow cytometry [13] After incubation for 72 h, cells were harvested with 0.25% trypsin and washed three times with PBS buffer for 100×g at 4 ºC for 8 min. The cell pellets were fixed with 70% ethanol at 4 ºC for 24 h. And the ethanol was washed off with PBS buffer. The cell pellets were added into 0.5 mL propidium iodide-DNA fluorescein staining solution for 30 min at 4 ºC. Then the mixture was put in the sample chamber to be examined at 488 nm of excitation wave. 10 000 cells were detected in every sample and the cell cycle was analyzed by Mod Fit 2.0 package (Becton Dickinson, USA).
Determining the quantity of collagen IV and laminin [14] The stored supernatant at -20 ºC was tested by radioimmunoassay kits from Shanghai High Biotech Center (Lot No 200506, Shanghai, China).
Immunocytochemistry measurements of Smad2/3 and Smad7 [15] The glass slides were pretreated with 10% polylysine, then placed on 24-well culture plates. The cells were transferred to the glass slides to incubate for 72 h. The supernatants were displaced and the cells were fixed by 4% paraformaldehyde (PFA) for 30 min. After permeation with 0.1% Triton-X-100 for 15 min, the cells were incubated with rabbit polyclonal anti-Smad2/3 at a dilution of 1:100 at 37 ºC for 2 h. After being washed, goat anti-rabbit IgG-horseradish peroxidase was added. To visualize Smad2/3, cells were stained with 3.3-diaminobenzidine (DAB) for 30 min and then examined by light microscopy (×400). All steps were performed at room temperature. Smad7 measurement was identical to Smad2/3. The stained Smad2/3 and Smad7 were quantified by gray scale analysis (Leica Qwin Standard V2.6; Leica Microsystems, Welzlar, Germany).
RT-PCR for the relative quantities of TGF-β 1 mRNA of mesangial cells [16] A reverse transcription polymerase chain reaction (RT-PCR) procedure was performed to determine the relative quantities of TGF-β 1 mRNA in mesangial cells, while β-actin mRNA, the house-keeping gene, was used as an internal control. Total RNA was extracted from mesangial cells with Promega Totle RNA Isolation system (Lot No 182207, Promega Corperation, Madison,WI,USA). The upstream and downstream primers for rat TGF-β 1 mRNA were 5'-CCCGCA-TCCCAGGACCTCTCT-3' and 5'-CGGGGGACTGGCG AGCC-TTAG-3', yielding a 519-bp product, whereas those for β-actin were 5'-GCTGCGTGTGGCCCCTGAG-3'and 5'-ACGCA-GGATGGCATGAGGGA-3', yielding a 252-bp product. Equal amounts (3 µL) of each total RNA sample were added in a 50 µL reaction mixture exerting one-step amplification with Promega RT-PCR system (Lot No 199676, Promega). The reaction mixture was incubated at 48 ºC for 45 min to reverse transcript, then went into cycles. The cycle conditions were set to: initial denaturation for 5 min at 94 ºC, 40 cycles at 94 ºC for 1 min, 57 ºC for 50 s, 72 ºC for 1 min, final elongation at 72 ºC for 7 min. The RT-PCR products were separated by 1% agarose electrophoresis, and the band densities were analyzed using laser densitometry. The relative quantities of TGF-β 1 mRNA in mesangial cells were represented by the ratio of band density of TGF-β 1 versus that of β-actin.
Measurement of oxidative stress in mesangial cells [14] Total antioxidative capability (T-AOC), catalase (CAT), total superoxidase dismutase (T-SOD) and glutathione-peroxidase (GSH-Px) activities of the stored supernatants were measured by spectrophotometry, using kits from Jiancheng Bioengineering Institute (Lot No 20050522, Nanjing, China). Statistical analysis Statistical analysis was performed to compare the effects of EGb on mesangial cells using oneway analysis of variance (ANOVA) and Dunnett's t-test (2-side) for different groups using SPSS 10.0. Data were expressed as the mean±SD. P<0.05 was considered statistically significant.
Results
Effect of EGb on cell cycle of mesangial cells
The cell cycle of ET group using 1.0% ethanol as solvent was of no significant difference to that of the NS group using normal sodium as solvent (P>0.05), which suggested that 1.0% ethanol had no significant effect on cell cycle and 1.0% ethanol could be used to incubate mesangial cells. The G 0 /G 1 phase percentage of the HG group was significantly higher and the S phase percentage was lower than that of the ET group (P<0.05 or P<0.01). When compared with those of the HG group, the G 0 /G 1 phase percentages of GL, GM, and GH were decreased and S phase percentages were increased in a concentration-dependent manner. The difference was significant (P<0.05 or P<0.01). The G 0 /G 1 phase and S phase percentages of GM had no great difference to those of the ET group, indicating that the moderate dose of EGb could reverse the cell cycle changes in high glucose. The G 0 /G 1 phase percentage of captopril was lowered and the S phase percentage was raised slightly, but they were not statistically significant (P>0.05) ( Table 1) .
Effects of EGb on collagen IV and laminin of mesangial cells
The levels of collagen IV and laminin of the ET group were of no significant difference to those of the NS group (P>0.05), suggesting that 1.0% ethanol had no significant effect on the cell expressions of collagen IV and laminin. The levels of collagen IV and laminin of the HG group were significant increased, when compared with those of the ET group (P<0.05 or P<0.01). Collagen IV levels of the GM, GH, and captopril group were strikingly lower than those of the HG group (P<0.05 or P<0.01). The level of the GH group was similar to that of the captopril group (P>0.05). Laminin levels of the GL, GM, GH, and captopril groups were all decreased (P<0.05 or P<0.01). These results suggested that EGb could decrease the expressions of collagen IV and laminin in mesangial cells and captopril's capability of decreasing expressions of collagen IV and laminin was between that of EGb's moderate and high dose (P>0.05) (Figure 1 ).
Immunocytochemistry analysis of Smad2/3 and Smad7 of mesangial cells Mesangial cells looked like an irregular star or a fusiform. The color of the stained Smad2/3 or Smad7 protein was brown. Smad2/3 or Smad7 was expressed in cytoplasm, but Smad2/3 could bind to Smad4 translocating into the nucleus. So Smad7 could be found only in the cytoplasm, whereas Smad2/3 could be seen in both the cytoplasm and nucleus (Figures 2 and 3) . The staining intensity of Smad2/3 of the HG group was highly increased and Smad7 was markedly decreased, when compared with those of the ET group. After the exposure of mesangial cells to EGb or captopril, the intensity of Smad2/3 became scarce and Smad7 became intense.
Using gray scale analysis to quantify Smad2/3 and Smad7 proteins, we found that the levels of Smad2/3 and Smad7 of the ET group were of no significant difference to those of the NS group (P>0.05), suggesting that 1.0% ethanol had no significant effect on the cell expressions of Smad2/3 and Smad7 (Figure 4) . Immunocytochemical micrographs of Smad7 in mesangial cells (original magnifications×400): Smad7 was found in the cytoplasm of mesangial cells. It was stained brown . The staining intensity of ET group was similar to that of NS group. The staining intensity of HG group showed markedly decreased. With the increasing concentration of EGb, the stain of Smad7 of GL, GM, and GH group became intense respectively, when contrasting to that of HG group. The staining intensity of captopril group was also increased.
Figure 2.
Immunocytochemical micrographs of Smad2/3 in mesangial cells (original magnifications×400): Smad2/3 was found in both cytoplasm and nucleus of mesangial cells. It was stained brown. The staining intensity of ET group was similar to that of NS group. The staining intensity of HG group showed strikingly increased. With the increasing concentration of EGb, the stain of Smad2/3 of GL, GM and GH group became scarce respectively, when contrasting to that of HG group. The staining intensity of captopril group was also decreased.
The level of Smad2/3 in the HG group was strikingly higher than that of the ET group and Smad7 was markedly lowered. They had significant difference when compared to those of the ET group (P<0.01). With the increasing concentration of EGb, the expressions of Smad2/3 in GL, GM, and GH were significantly decreased (P<0.01). The expressions in the captopril group were also decreased (P<0.01), and the level of Smad2/3 in the captopril group was between the GL group and GM group. The captopril group and the high dose of EGb could significantly increase the expression of Smad7 (P<0.01). The moderate dose of EGb also increased the expression of Smad7, but it had no significant difference when compared to that of the HG group. All of these results suggested that EGb had a potent influence on cell expressions of Smad2/3 and Smad7 and EGb could reverse the changes of Smad2/3 and Smad7 when mesangial cells were exposed to high glucose.
Effect of EGb on the relative quantity of TGF-β 1 mRNA of mesangial cells The RT-PCR products of TGF-β 1 were separated by 1% agarose electrophoresis, after which we could see distinct bands ( Figure 5A ). The relative quantity of TGF-β 1 mRNA of the ET group was of no significant difference to that of the NS group (P>0.05), suggesting that 1.0% ethanol had no significant effect on the cell expression of TGF-β 1 mRNA.
The relative quantity of TGF-β 1 mRNA of the HG group was greatly higher than that of the ET group (P<0.01). The TGF-β 1 mRNA level of the GH group and captopril group was strikingly decreased when compared with that of the HG group (P<0.05). The levels of the GL and GM group were also decreased, but the differences were not significant (P> 0.05). The level of the GH group was similar to that of the Figure 5B ).
Effects of EGb on oxidative stress
The CAT, GSH-Px, T-AOC, and T-SOD activities of the ET group were of no significant difference to those of the NS group (P>0.05), suggesting that 1.0% ethanol had no significant effect on the cell antioxidative indexes activities. The activities of the four antioxidases of HG were all lower than those of the ET group (P<0.05 or P<0.01), suggesting that mesangial cells in high glucose displayed oxidative stress. We also found that moderate and/or high doses of EGb increased the four antioxidases activities (P<0.05 or P<0.01). The activities of the GL group also increased but the differences were not significant. These results indicated that EGb could ameliorate the oxidative stress state of mesangial cells in high glucose. Captopril also significantly increased CAT and GSH-Px activities (P<0.05), but it had no evident effect on T-AOC and T-SOD (P>0.05) ( Figure 6 ).
Discussion
Mesangial cells are a special kind of cell that can synthesize and secrete many protein factors regulating the structure and function of glomerulus. Alteration in mesangial cell function is central to the progression of glomerular disease in numerous models of chronic renal failure. It has been found that high glucose can stimulate the expression of Ang II, ROS, and TGF-β 1 [17] . Ang II may directly induce the irregularity of hemodynamics in the kidneys, and may also stimulate the expression of TGF-β 1 , ROS, and ECM. TGF-β 1 itself can also induce accumulation of ECM mediated by signals such as MAPK, Smads, PKC, PKA, Ca
2+
, and so on, and the signals interact with each other constituting a complicated network which leads DN to aggravation [8] . The Smads protein is thought to be one of the most important factors in the process of ECM accumulation. Researchers have found that mesangial cell hypertrophy and the accumulation of ECM in the mesangial region consists mainly of glomerular sclerosis, while the autocrining cytokines of mesangial cells is a nonignored element. The manifestations of diabetic nephropathy may be a consequence of the actions of certain cytokines and growth factors. Therefore, the research of mesangial cells has been a warm spot in DN research. In addition to blocking RAS and suppressing oxidative stress and TGF-β 1 expression, the interference in Smads signals following TGF-β 1 would be a new pathway to delay the progression of DN.
Cell cycle is an elementary process in vital movements of Figure 6 . Effects of EGb on CAT (A), GSH-Px (B), T-AOC (C), and T-SOD (D) activities of mesangial cells. NS, ET, HG, GL, GM, GH, and captopril represent normal glucose group, solvent control group, high glucose group, 10 µg/mL EGb group, 20 µg/mL EGb group, 40 µg/mL EGb group, and 1 µmol/mL captopril group, respectively. Mean±SD. [18] . This neutralization experiment clearly demonstrates that TGF-β 1 is a necessary prerequisite for the development of cell hypertrophy. G 1 growth arrest is regulated by many elements of cell cycle machinery. Among regulators of G 1 progression, the increased cyclin inhibitors p27 and p21 have been recognized as main regulators of TGF-β 1 -induced cell-cycle arrest in DN [19, 20] . Flow cytometry is a technique for analyzing unicells rapidly. The cell cycle is analyzed acting on DNA contents. In our present study, we found that the percentage of G 0 /G 1 in the HG group was increased and S phase percentage was decreased accompanied by increased TGF-β 1 , which is consistent with former reports [7, 19] . When cells were cocultured with EGb, G 0 /G 1 percentage was decreased, while the S percentage was increased correspondingly in a concentration-dependent manner. We also found that a middle dose of EGb could reverse the cell cycle changes in high glucose, which indicates that EGb has a potent effect on cytoprotective action, and that captopril do not significantly affect the cell cycle. All of these results demonstrate that high glucose/TGF-β 1 induce the G 1 -phase arrest stimulating cell hypertrophy and that EGb could strikingly raise S phase percentage, therefore leading cells to surpass G 1 /S restriction. In this respect, EGb might have much more protection on mesangial cells than captopril. It has been found quercetin could suppress cell hypertrophy by degrading the expression of p27 in glomerulus [21] . But little is known about EGb's cell protection, so it would be worthwhile to further investigate its potential mechanisms of manifold ingredients on cell cycle.
The accumulation of ECM is the result of imbalance between synthesis system such as plasminogen activator inhibitor-1 and TIMP and resolution system including matrix metalloproteinase. TGF-β 1 is closely associated with the accumulation of mesangial ECM. The Smads protein following TGF-β 1 is thought to be one of the most important factors in the process of ECM accumulation. In our experiment, the expressions of collagen IV and laminin of the HG group were strikingly increased. To trace back to their upstream signals, we found the expressions of Smad2/3 and the relative TGF-β 1 level were also increased, while the inhibitory signal Smad7 was decreased. This indicates that it is high glucose that initially induces the increased expression of TGF-β 1 , ultimately resulting in the accumulation of collagen IV and laminin. In other words, it is the activated TGF-β 1 / Smads signal pathway that induces the accumulation of ECM. TGF-β 1 /Smads/ECM is obviously a linked response. Our results are in correspondence with other colleagues [22] . After cells were incubated with EGb, the expressions of TGF-β 1 and Smad2/3 were lowered significantly, and Smad7 was raised greatly, suggesting that EGb suppress the TGF-β 1 / Smads/ECM response when mesangial cells are composed to high glucose. Recently Ang II blockade is rapidly becoming a standard antifibrotic therapy in renal diseases, and its mechanism has been a theme of research [23] . It is largely because ACE-inhibitors block up TGF-β 1 induced by Ang II. Colleagues have proved that it is by suppressing TGF-β 1 / Smads signal pathway that ACE-inhibitors (N-acetyl-serylaspartyl-lysyl-proline, Ac-SDKP) decrease the accumulation of ECM in mesangial cells [24] . In our study we also found that an ACE-inhibitor (captopril) had a potent effect on suppressing ECM. The effect of EGb on ECM is similar to that of captopril. We know that the hypertrophic cells could express more ECM, so the potent effect of EGb suppressing ECM expression might be inseparable from its action of powerfully regulating cell cycle.
Oxidative stress has been known to play an important role in the development and progression of DN, and ROS is a direct consequence of hyperglycemia. It has been found that TGF-β 1 and AGE could also activate ROS [25] . ROS activates other signaling molecules, such as PKC and MAPK and transcription factors including NF-kappa B, activator protein-1 and specificity protein 1 leading to a transcription of genes encoding cytokines, growth factors, and ECM proteins, all of which are closely relative to DN [26] . Various antioxidants inhibit mesangial cell activation by high glucose and ameliorate features of DN. It has been reported that the glucose-induced collagen IV expression can be partially reversed by the addition of two structurally unrelated antioxidants, trolox and α-lipoic acid, in porcine mesangial cells [3] . So antioxidant treatment is a potential antifibrotic therapy. N-acetylcysteine, a classic antioxidant, was used as an effective antifibrotic drug by some scholars [27] . In our study, after the cells were incubated with EGb, we found that CAT, T-AOC, T-SOD, and GSH-Px activities (common indicators for changes in the antioxidation system) were all increased significantly accompanied by decreased collagen IV and laminin expressions, strongly suggesting that EGb has a potent antioxidative capability and antifibrotic capability in vitro. This result is consistent with a former report, in which EGb suppressed oxidized LDL-stimulated fibronectin production through an antioxidant action in rat mesangial cells [28] . In another report EGb was used as a free radical scavenger [10] . The control drug captopril also had significant effects on enhancing CAT and GSH-Px activities, but had no significant effect on T-AOC and T-SOD. These data suggest that EGb may have a more profound effect than captopril on ameliorating the oxidative stress state of mesangial cells and antifibrotic action.
More recently, scholars have paid more attention to the interaction between ROS and TGF-β 1 /Smads in DN. It has been found that AGE-RAGE-mediated ROS generation activates TGF-β 1 -Smads signals and subsequently induces mesangial cell hypertrophy and fibronectin synthesis by autocrine production of Ang II [25] . It has also been found that H 2 O 2 mediated the activation of ERK with the Smads pathway in TGF-β 1 induction of p21 [29] . Therefore, we could conclude that ROS and TGF-β 1 /Smads signals interact mutually and upregulate each other in the pathogenesis of DN. In our present study, we could see that EGb could act as an antioxidant suppressing TGF-β 1 -Smads signals and could also suppress TGF-β 1 expression ameliorating the oxidative stress state. Both observations could suppress ECM accumulation and cell hypertrophy in mesangial cells. Therefore, the non-hemodynamic effects of EGb on DN are also significant.
In conclusion, EGb can regulate the mesangial cell cycle, ameliorate oxidative stress state, suppress the accumulation of collagen IV and laminin, decrease TGF-β 1 and Smad2/3, and increase Smad7 expressions in cultured cells. That is to say, EGb can suppress cell hypertrophy and the accumulation of ECM mediated by TGF-β 1 /Smads and ROS signals on cell levels, which means it could vitally postpone glomerulosclerosis of DN.
